{
}
Barclays has increased its price target for Quest Diagnostics Incorporated from $175 to $185. As the leading provider of diagnostic testing and information services, Quest Diagnostics generates 97% of its net sales from testing and diagnostic services, including routine clinical and gene-based testing.
UBS has raised its price target on Quest Diagnostics to $170 from $166 while maintaining a Neutral rating. Quest Diagnostics is the leading provider of diagnostic testing and information services, with 97% of its net sales coming from testing and diagnostic services, including routine clinical and gene-based testing.
The global Precision Medicine market, valued at $89.9 billion in 2023, is projected to reach $161.1 billion by 2030, growing at a CAGR of 8.7%. Key drivers include advancements in genomic sequencing, rising chronic disease prevalence, and increased investment in targeted therapies, particularly in oncology. The integration of AI and machine learning is further enhancing personalized treatment approaches, paving the way for more effective healthcare solutions.
The preventive healthcare technologies and services market is projected to grow from $259.84 billion in 2023 to $541.36 billion by 2028, driven by an aging population and advancements in digital health. Key players are innovating with advanced preventative care programs, such as WELL Longevity+, which integrates AI and diagnostic imaging to enhance early intervention strategies.
The Global Diagnostics Rapid Test Kits market is projected to experience significant growth from 2024 to 2031, driven by advancements in technology and the presence of major players, particularly in North America and Europe. The market is expected to reach multimillion USD by 2031, despite intense competition, as investors remain optimistic about new opportunities. Comprehensive analysis covers market segmentation, trends, and key players, providing insights for strategic decision-making.
The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
The Healthcare Revenue Cycle Management market is experiencing significant growth, driven by increased demand, a broader customer base, and technological advancements. A comprehensive report analyzes market size, trends, competitive landscape, and future growth prospects, highlighting key players like Athena Health and McKesson Corporation. The report also delves into market segmentation, consumption patterns, and pricing strategies, providing valuable insights for stakeholders in the industry.
Quest Diagnostics Incorporated is the leading provider of diagnostic tests and information services for patients and healthcare professionals. The company's net sales are primarily derived from tests and diagnostic services, which account for 97% of revenue, including routine clinical tests, genetic tests, and advanced diagnostic services. The remaining 3% comes from other activities.
Quest Diagnostics Incorporated
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
barclays increases quest diagnostics price target to 185 dollars from 175 dollars
20:42 22.04.2025
ubs raises quest diagnostics price target to 170 maintains neutral rating
16:06 03.02.2025
global precision medicine market projected to reach 161 billion by 2030
SIEMENS HEALTHINEERS
Medtronic plc
Quest Diagnostics Incorporated
Genesis Healthcare, Inc.
Abbott Laboratories
Myriad Genetics Inc
BIOGEN
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
DEU
CAN
CHN
JPN
USA
Show more
14:51 13.12.2024
preventive healthcare technologies market poised for significant growth by 2028
McKesson Corporation
Alere Inc.
Omnicell Inc
Medtronic plc
Merck & Co., Inc.
Walgreens Boots Alliance Inc
Quest Diagnostics Incorporated
Cerner Corporation
Glaxosmithkline plc
Myriad Genetics Inc
Healthways Inc.
Teladoc Health Inc
Pfizer Inc.
ModivCare Inc.
Vocera Communications Inc.
Novartis AG
Tivity Health Inc.
Sanofi SA
Change Healthcare Inc.
Allscripts Healthcare Solutions Inc
GRAIL Inc
Show more
11:23 09.12.2024
global diagnostics rapid test kits market poised for significant growth by 2031
United States Dollar
Shimadzu Medical (India) pvt. Ltd.
General Electric Company
Quest Diagnostics Incorporated
NeuroLogica Corp.
Koninklijke Philips N.V.
PHL
ARG
GBR
IDN
COL
FRA
ITA
MYS
TUR
KOR
ZAF
MEX
USA
BRA
NLD
THA
SAU
EGY
CAN
VNM
ARE
NGA
JPN
AUS
DEU
CHN
RUS
IND
Show more
11:41 19.11.2024
global healthcare services market poised for significant growth through 2028
United States Dollar
Community Health Systems, Inc.
UnitedHealth Group Incorporated
CVS Health Corporation
Regeneron Pharmaceuticals, Inc.
Cardinal Health, Inc.
Fresenius Medical Care AG & Co. KGaA
Centene Corporation
Baxter International Inc.
Mayo Clinic
Agilent Technologies, Inc.
Johnson & Johnson
Pfizer Inc.
Cleveland Clinic Global Solutions LLC
McKesson Corporation
Merck & Co., Inc.
Abbott Laboratories
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
HCA Healthcare, Inc.
Gilead Sciences, Inc.
Kaiser Permanente Group Trust
Cigna Corporation
Stryker Corporation
Tenet Healthcare Corporation
Danaher Corporation
AbbVie Inc.
Boston Scientific Corporation
Molina Healthcare, Inc.
Align Technology, Inc.
AmerisourceBergen Corporation
Laboratory Corporation OF America Holdings
DaVita Inc.
Eli Lilly and Company
Humana Inc.
West Pharmaceutical Services, Inc.
Fresenius Medical Care AG & Co. KGaA
Kaiser Permanente
UnitedHealth Group Incorporated
Tenet Healthcare
HCA Healthcare
Show more
20:40 11.11.2024
healthcare revenue cycle management market poised for significant growth through 2031
United States Dollar
McKesson Corporation
Cerner Corporation
Quest Diagnostics Incorporated
Experian PLC
Genesis Healthcare, Inc.
Joe Biden
Alice Mutum
Show more
07:04 28.10.2024
ubs maintains neutral rating for quest diagnostics amid strong market position
15:31 23.10.2024
Trending
Subcategory
Stock Market Updates
Industry Trends
Corporate News
Retail and Consumer Goods
Global Financial Events
Finance Mergers & Acquisitions
Startups & Entrepreneurship
AI Innovations
Funding Rounds & Investments
Government Policies
Market Analysis and Predictions
Central Bank Actions
Industry Mergers & Acquisitions
Supply Chain Management
AI & Automation Regulations
Banking Regulations
Domestic Politics
Global Trade Developments
Emerging Startups
Government Economic Policies
Countries:
Companies:
NVIDIA Corporation
Apple Inc.
Huawei Technologies CO. Ltd.
Tesla, Inc.
The Goldman Sachs Group, Inc.
Citigroup Inc.
Barclays PLC
Wells Fargo & Company
American Express Co
Bank of America Corporation
Tiktok USD
HSBC Holdings plc
Berkshire Hathaway Inc.
International Monetary Fund FUND
HDFC Bank Ltd
Coca-Cola FEMSA, S.A.B. de C.V.
Nintendo Co., Ltd.
Raiffeisen Bank International AG
Pfizer Inc.
VP Bank AG
Currencies:
United States Dollar
Euro
Japanese Yen
Indian Rupee
Chinese Yuan
United Arab Emirates Dirham
Swiss Franc
British Pound Sterling
Offshore Chinese Yuan
Brazilian Real
Saudi Riyal
Australian Dollar
South Korean Won
Hong Kong Dollar
Norwegian Krone
People: